Pre- and postnatal brain development in neonates with congenital hypothyroidism

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue SUPPL. 6, 2001, Pages 1463-1468

  Bongers Schokking, Jacoba J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Brain development; Congenital hypothyroidism; Levothyroxine dosage; Neonates; Skeletal maturation

Indexed keywords

BRAIN; CONGENITAL HYPOTHYROIDISM; FETUS; GROWTH; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYPOTHYROIDISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW;

BRAIN; CONGENITAL HYPOTHYROIDISM; EMBRYONIC AND FETAL DEVELOPMENT; FETUS; GROWTH; HUMANS; HYPOTHYROIDISM;

EID: 0035565732     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tillotson SL, Fuggle PW, Smith I, Ades AE, Grant DB. Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect. BMJ 1994; 309: 440-445.
2. Derksen-Lubsen G, Verkerk PH. Neuropsychological development in early treated congenital hypothyroidism: analysis of literature data. Pediatr Res 1996; 39: 561-566.
3. Campos SP, Sandberg DE, Barrick C, Voorhees ML, MacGillivray MH. Outcome of lower L-thyroxine treatment of congenital hypothyroidism. Clin Paediatr 1995; 34: 514-520.
4. Komianou F, Makaronis G, Lainbadaris J, Sarafidou E, Vrachni F, Mengreli C, Pantelakis S. Psychomotor development in congenital hypothyroidism. The Greek screening programme. Eur J Pediatr 1988; 147: 275-278.
5. Dubuis JM, Glorieux J, Richter F, Deal CL, Dussault JH, van Vliet G. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab 1996; 81: 222-227.
6. Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995; 126: 380-386.
7. Bongers-Schokking JJ, Koot HM, Verkerk PH, de Muinck Keizer-Schrama SMPF. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000; 136: 292-297.
8. Germak JA, Foley TP. Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1990; 117: 211-219.
9. Nelson JC, Clark SJ, Borut DL, Tomei RT, Carlton EI. Age-related changes in free thyroxine during childhood and adolescence. J Pediatr 1993; 123: 899-905.
10. Garcia M, Calzada R, Pérez G, Martinez Gigena MP, González RA, de la Luz Ruiz Reyes M. Congenital hypothyroidism: effect of the dose of levothyroxine on thyroid hormone levels and bone age. Horm Res 1997; 48 (Suppl 2): 161 [Abst].
11. Schwartz ID, Turner K, Kruger T, Bennett D, Howard CP, Grunt JA. Neuropsychological outcome in children with congenital hypothyroidism treated with varying amounts of levothyroxine during the first 2 years of life. Int Pediatr 1994; 9: 254-259.
12. Wolter R, Noel P, de Cock P, Craen M, Ernould C, Malvaux P, Verstaeten F, Simons J, Mertens S, van Broeck N, Vanderschueren-Lodeweyckx M. Neuropsychological study in treated thyroid dysgenesis. Acta Paediatr Scand 1979; Suppl 277: 41-44.
13. Glorieux J, Desjardins M, Letarte M, Morisette J, Dussault JH. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr Res 1988; 24: 6-8.
14. Fisher DA. The importance of early management in optimizing IQ in infants with congenital hypothyroidism. J Pediatr 2000; 136: 273-274.
15. Bongers-Schokking JJ, Colon EJ, Hoogland RA, de Groot CJ, van den Brande JL. Somatosensory evoked potentials in neonates with primary congenital hypothyroidism during the first week of therapy. Pediatr Res 1991; 30: 34-39.
16. Bongers-Schokking JJ, Colon EJ, Mulder PGH, Hoogland RA, de Groot CJ, van den Brande JL. Influence of treatment on the maturation of the somesthetic pathway in infants with primary congenital hypothyroidism during the first year of life. Pediatr Res 1993; 34: 73-78.
17. Desmedt JE, Brunko E, Debecker J. Maturation of the somatosensory evoked potentials in normal infants and children, with special reference to the early N1 component. Electroencephalogr Clin Neurophysiol 1967; 40: 43-58.
18. Hrbek A, Fallstrom SP, Karlberg P, Olssen T. Clinical application of evoked EEG responses in infants. III. Congenital hypothyroidism. Dev Med Child Neurol 1982; 24: 164-176.
19. Sénécal J, Grosse MC, Vincent A, Simon J, Lefrèche JN. Maturation osseuse de foetus et du nouveau-né. Arch Fr Pédiatr 1977; 34: 424-438.
20. Silva JE, Matthews PS. Production rates and turnover of triiodothyronine in rat developing cerebral cortex and cerebellum: responses to hypothyroidism. J Clin Invest 1984; 74: 1035-1049.
21. Calvo R, Obregon MJ, Ruiz de Oña C, Escoral del Rey F, Morreale de Escobar G. Congenital hypothyroidism, as studied in rats: crucial role of maternal thyroxine but not 3,5,3′-triiodothyronine in the protection of the fetal brain. J Clin Invest 1990; 86: 889-899.
22. Camilot M, Valentini R, Antoniazzi F, Tagliaro F, Mangarda F, Tatò L. CNS myelinization and type II deiodase activity in congenital hypothyroidism: result of thyroid hormones hair analysis. ESPE/LWPES Joint Meeting, Stockholm, Sweden. 1997; Miniposters, p. 51.
23. Vulsma T, Gons MH, de Vijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989; 321: 13-16.